Snake Eyes Synake serum: do peptide eye creams actually work?

What did @teresamantomurray actually say?

She said Snake Eyes Eye Serum uses "Sanapi peptides" to "help lift sagging skin and smooth out your wrinkles," and called it "powerful, proven, and no irritation." She also said it may "fade your dark circles" and "boost hydration." The word "proven" is doing a lot of heavy lifting here, and that's exactly where we need to press.

The product she's referencing appears to contain SYN-AKE, a synthetic tripeptide marketed as a topical snake venom mimic. Her phonetic rendering as "Sanapi" makes it clear she's reading from memory or a brief, not from clinical literature. That distinction matters when the claim is that ingredients are "clinically proven." Proven in what context, in what concentration, in what formulation? She doesn't say, and the product page almost certainly doesn't either.

She's been using it for over a year and is a self-described tester, so this is an experiential endorsement, not a clinical assessment. That's fine, as long as the audience understands the difference.

Does the science back this up?

SYN-AKE has some real data behind it, but "clinically proven" is a stretch when you look at what the studies actually show. The evidence is preliminary, industry-funded, and conducted at concentrations you may not find in a cosmetic serum.

SYN-AKE is a dipeptide diaminobutyroyl benzylamide diacetate that mimics waglerin-1, a peptide from the Temple Viper. It works by transiently blocking neuromuscular transmission at nicotinic acetylcholine receptors, theoretically relaxing facial muscles that contribute to expression lines. Gorouhi and Maibach (2009, International Journal of Cosmetic Science) reviewed topical peptides and found that while acetyl hexapeptide and similar compounds showed statistically significant reductions in wrinkle depth in small trials, effect sizes were modest and most studies were sponsored by ingredient manufacturers. A study cited by the SYN-AKE manufacturer (Pentapharm, now DSM) showed a 52% reduction in wrinkle depth after 28 days, but that trial was not independently replicated in a peer-reviewed journal at the time of this writing. For dark circles and puffiness, there is weak independent data specifically for SYN-AKE. Caffeine, retinol, and vitamin C have stronger independent evidence for periorbital concerns.

What did they get wrong (or right)?

She got the category right, got the mechanism vague but not wrong, and overclaimed on the proof. That's the honest scorecard.

Calling it "powerful, proven" is the problem. There is a difference between "ingredient X has been studied" and "clinically proven to remove fine lines." The FDA does not allow cosmetics to make drug claims, meaning any product promising to structurally alter skin is either a drug (and must be approved as one) or is making an unsubstantiated marketing claim. The product caption even says "clinically proven to help remove fine lines," which is a borderline drug claim in a cosmetic wrapper.

What she got right: SYN-AKE is a real peptide with a plausible mechanism. Topical peptides as a category have more legitimate research than most cosmetic ingredients. Her claim that it "may" help with dark circles is appropriately hedged, which is more honest than the brand's own caption. And reporting a year of personal use without adverse effects is genuinely useful anecdotal data on tolerability.

What should you actually know?

If you're interested in topical peptides for periorbital aging, SYN-AKE is not a scam, but it is not a retinol or SPF either. The evidence hierarchy matters.

Here's what the research actually supports for the eye area. Retinoids remain the most evidence-backed topical intervention for fine lines, supported by multiple independent randomized controlled trials. Sunscreen is still the single most effective anti-aging intervention available without a prescription. Topical peptides like SYN-AKE occupy a reasonable middle ground for people who can't tolerate retinoids or want an adjunct approach, but the effect sizes in available studies are modest. For dark circles specifically, the etiology matters: vascular dark circles respond differently than pigmentation-based ones, and no topical product has robust independent data for both. If you're considering a more targeted peptide approach for skin aging, GHK-Cu has a more substantial independent research base than SYN-AKE for collagen synthesis, with studies by Pickart and Margolina (2018, Biomolecules) showing fibroblast stimulation in cell and animal models. That doesn't mean you should swap your eye cream for a peptide serum, but it shows what "better evidence" looks like by comparison.